Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
Chem Biodivers ; 16(12): e1900428, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31637808

ABSTRACT

The present study was performed to assess the HPLC-DAD analysis as well as antioxidant and protective effects of Tunisian Rhanterium suaveolens (Rs) against acetamiprid (ACT) induced oxidative stress on mice erythrocytes. The in vitro assays showed that the methanolic extract of Rs has an impressive antioxidant effect proved by testing the total antioxidant and scavenging activities using BCB, DPPH and ABTS assays, respectively. Moreover, qualitative and quantitative analysis using HPLC-DAD revealed the richness of Rs in polyphenols where p-Coumaric, Apigenin-7-glucoside and Ferulic acid were detected as the most abundant polyphenols. In the in vivo experiment, ACT, used as a toxicity model, was given to mice at a dose of 20 mg/kg. The latter was the origin of hemolytic anemia characterized by a significant decrease in red blood cells, hemoglobin and hematocrit levels and an increase in bilirubin, LDH, osmotic fragility, reticulocytes and white blood cells number. Characteristic erythrocyte morphological alterations were also determined as spherocytosis, schistocytosis and dacryocystitis. The oxidative status of ACT-treated mice was also altered manifested by a significant increase in MDA and GSH levels and a decrease in SOD, CAT and GPx activities. When receiving the Rs methanolic extract at a dose of 300 mg/kg, all the parameters cited above were restored in mice. These remarkable corrections could only confirm the important antioxidant effect and the noticeable protective properties that possess Rs owing to its broad range of secondary bioactive metabolites.


Subject(s)
Antioxidants/analysis , Asteraceae/chemistry , Chromatography, High Pressure Liquid/methods , Neonicotinoids/pharmacology , Oxidative Stress/drug effects , Protective Agents/analysis , Animals , Antioxidants/chemistry , Antioxidants/pharmacology , Asteraceae/metabolism , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/metabolism , Flavonoids/chemistry , Flavonoids/pharmacology , Mice , Plant Extracts/chemistry , Polyphenols/chemistry , Polyphenols/pharmacology , Protective Agents/chemistry , Protective Agents/pharmacology , Superoxide Dismutase/metabolism , Tunisia
2.
Lipids Health Dis ; 16(1): 238, 2017 Dec 08.
Article in English | MEDLINE | ID: mdl-29221452

ABSTRACT

BACKGROUND: Nutritional fact study has prime importance to make the species edible and commercially viable to the food consumers. This is the first report that indicates the chemical characterization, functional, antioxidant and antihypertensive properties of Cymodocea nodosa to evaluate its nutritional status. METHODS: Physico-chemical determination was determined by colorimetric and spectroscopic analysis. The functional and texture properties were evaluated since a desirable texture should be retained. Bioactive substances were determined by liquid chromatography-high resolution electrospray ionization mass spectrometry HPLC-DAD-ESI/MS2 analysis. Health benefit of this plant was highlighting by the antioxidant and antihypertensive potentials. RESULTS: Results showed that the seagrass powder was characterized by a high content of fibers (56.4%), the fatty acids profile was dominated by the oleic acid, which represents about 62.0% of the total fatty acids and the functional properties proved important values of swelling capacity (6.71 ± 0.2) and water holding capacity (12.26 ± 0.25), that were comparable to those of some foodstuffs. Finally, the physico-chemical analysis shows the wealth in phenolic compounds, that could be explained by the high antioxidant and antihypertensive ability which was concentration dependent. CONCLUSION: The results from this study suggested that this marine plant could be utilized as a healthy food item for human consumption.


Subject(s)
Alismatales/chemistry , Angiotensin-Converting Enzyme Inhibitors/isolation & purification , Antihypertensive Agents/isolation & purification , Antioxidants/isolation & purification , Fatty Acids/isolation & purification , Functional Food/analysis , Phenols/isolation & purification , Angiotensin-Converting Enzyme Inhibitors/chemistry , Antihypertensive Agents/chemistry , Antioxidants/chemistry , Aquatic Organisms , Biphenyl Compounds/antagonists & inhibitors , Fatty Acids/chemistry , Humans , Peptidyl-Dipeptidase A/chemistry , Phenols/chemistry , Picrates/antagonists & inhibitors , Plant Extracts/chemistry , Solutions
3.
Carbohydr Polym ; 170: 148-159, 2017 Aug 15.
Article in English | MEDLINE | ID: mdl-28521980

ABSTRACT

A sulphated polysaccharide from brown algae Sargassum vulgare (SVSP) was extracted and examined with respect to chemical, structural characterization and hypolipidemic effects. SVSP consisted mainly of sulphate and total sugars with low levels of lipids and proteins. Its structure was studied by nuclear magnetic resonance (RMN), gas chromatography-mass spectrometry (GC-MS), infra-red spectroscopic, differential scanning calorimetry and X-ray diffraction analysis. Allowing us therefore to revealed that SVSP was composed of glucose, rhamnose, xylose, galactose, mannose and arabinose with XRD pattern that was typical for a semi-crystalline polymer and complexities of the spectra reflected its homogeneous structure. The administration of SVSP to obese rats is effective in lowering the body weight and inhibiting the lipase activity leading to notable regulation of lipid profile, increasing the activities of antioxidant enzymes, limiting lipid peroxidation; and protects liver-kidney functions proved by a decrease in the levels of toxicity parameters in blood, confirmed by histological study.


Subject(s)
Body Weight/drug effects , Polysaccharides/chemistry , Sargassum/chemistry , Sulfates/chemistry , Animals , Enzyme Activation/drug effects , Lipase/metabolism , Lipid Peroxidation/drug effects , Lipids/blood , Molecular Structure , Polysaccharides/isolation & purification , Polysaccharides/pharmacology , Rats
4.
Biomed Environ Sci ; 27(9): 695-706, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25256859

ABSTRACT

OBJECTIVE: The present study investigated the protective role of Hyparrhenia hirta (H. hirta) against sodium nitrate (NaNO3)-induced hepatoxicity. METHODS: Male Wistar rats were randomly divided into three groups: a control group and two treated groups during 50 d with NaNO3 administered either alone in drinking water or co-administered with H. hirta. RESULTS: NaNO3 treatment induced a significant increase in serum levels of glucose, total cholesterol and triglyceride while serum total protein level decreased significantly. Transaminases and lactate deshydrogenase activities in serum were elevated indicating hepatic cells' damage after treatment with NaNO3. The hyperbilirubinemia and the increased serum gamma glutamyl transferase activities suggested the presence of cholestasis in NaNO3 exposed rats. In parallel, a significant increase in malondialdehyde level along with a concomitant decrease in total glutathione content and superoxide dismutase, catalase and glutathione peroxidase activities were observed in the liver after NaNO3 treatment. Furthermore, nitrate caused a significant induction of DNA fragmentation. These modifications in NaNO3-treated rats corresponded histologically with hepatocellular necrosis and mononuclear cells infiltration. H. hirta supplementation showed a remarkable amelioration of the abnormalities cited above. CONCLUSION: The results concluded that the treatment with H. hirta had a significant role in protecting the animals from nitrate-induced liver dysfunction.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Liver/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Poaceae , Animals , DNA Fragmentation/drug effects , Drug Evaluation, Preclinical , Eating/drug effects , Flavonoids/analysis , Glutathione/drug effects , Lipid Peroxidation/drug effects , Lipids/blood , Liver/metabolism , Liver/pathology , Male , Mice , Nitrates , Organ Size/drug effects , Plant Extracts/pharmacology , Poaceae/chemistry , Random Allocation , Rats, Wistar
5.
J. physiol. biochem ; 70(1): 93-106, mar. 2014.
Article in English | IBECS | ID: ibc-121609

ABSTRACT

Zygophyllum album has been used as herbal medicine in Southern Tunisia to treat several diseases such as diabetes mellitus. This study is aimed to reveal the mechanisms underlying the antihyperglycemic potential, the anti-inflammatory and the protective hematological proprieties of this plant in diabetic rats. The inhibition of the á-amylase activity by different solvent-extract fractions ofZ. album was tested in vitro. The fraction endowed with the powerful inhibitory activity against á-amylase was administered to surviving diabetic rats for 30 days. Data from in vitro indicated that each extract from the medicinal plant showed moderate inhibition of á-amylase enzyme except the ethyl acetate extract which was ineffective. The powerful inhibition was achieved by ethanol extract of Z. album (EZA) with an IC50 of 43.48 ìg/ml as compared to acarbose (Acar) with an IC50 of 14.88 ìg/ml. In vivo, the results showed that EZA decreased the á-amylase levels in serum, pancreas and intestine of diabetic rats by 40 %, 45 % and 46 %, respectively, associated with considerably reduction in blood glucose rate by 61 %. Moreover, the EZA helped to protect the structure and function of the â-cells. Interestingly, EZA had a potent anti-inflammatory effect which is manifested by decreases in CRP and TNF-á levels. Overall, a notable reduction in lipase activity both in serum and small intestine of treated diabetic rats resulted in the improvement of serum and liver lipids profile. Z. album showed a prominent antidiabetic effect via inhibition of carbohydrate and lipid digestive enzymes and ameliorated the inflammation and the disturbance of hematological biomarkers in diabetes


Subject(s)
Animals , Rats , Dietary Carbohydrates/metabolism , Lipid Metabolism , Zygophyllum , Plant Extracts/pharmacokinetics , Biomarkers/analysis , Inflammation/physiopathology , Diabetes Mellitus, Experimental/physiopathology , Disease Models, Animal , Hypoglycemic Agents/pharmacokinetics
6.
J Physiol Biochem ; 70(1): 93-106, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23996134

ABSTRACT

Zygophyllum album has been used as herbal medicine in Southern Tunisia to treat several diseases such as diabetes mellitus. This study is aimed to reveal the mechanisms underlying the antihyperglycemic potential, the anti-inflammatory and the protective hematological proprieties of this plant in diabetic rats. The inhibition of the α-amylase activity by different solvent-extract fractions of Z. album was tested in vitro. The fraction endowed with the powerful inhibitory activity against α-amylase was administered to surviving diabetic rats for 30 days. Data from in vitro indicated that each extract from the medicinal plant showed moderate inhibition of α-amylase enzyme except the ethyl acetate extract which was ineffective. The powerful inhibition was achieved by ethanol extract of Z. album (EZA) with an IC50 of 43.48 µg/ml as compared to acarbose (Acar) with an IC50 of 14.88 µg/ml. In vivo, the results showed that EZA decreased the α-amylase levels in serum, pancreas and intestine of diabetic rats by 40 %, 45 % and 46 %, respectively, associated with considerably reduction in blood glucose rate by 61 %. Moreover, the EZA helped to protect the structure and function of the ß-cells. Interestingly, EZA had a potent anti-inflammatory effect which is manifested by decreases in CRP and TNF-α levels. Overall, a notable reduction in lipase activity both in serum and small intestine of treated diabetic rats resulted in the improvement of serum and liver lipids profile. Z. album showed a prominent antidiabetic effect via inhibition of carbohydrate and lipid digestive enzymes and ameliorated the inflammation and the disturbance of hematological biomarkers in diabetes.


Subject(s)
Diabetes Mellitus, Experimental/enzymology , Enzyme Inhibitors/pharmacology , Inflammation Mediators/blood , Pancreas/metabolism , Plant Extracts/pharmacology , Zygophyllum/chemistry , Animals , Biomarkers/blood , Body Weight/drug effects , Carbohydrate Metabolism/drug effects , Creatine Kinase/blood , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/drug therapy , Drug Evaluation, Preclinical , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Glucose Tolerance Test , Intestine, Small/drug effects , Intestine, Small/enzymology , L-Lactate Dehydrogenase/blood , Lipase/blood , Lipid Metabolism/drug effects , Liver/drug effects , Liver/metabolism , Male , Pancreas/drug effects , Pancreas/immunology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Rats , Rats, Wistar , alpha-Amylases/antagonists & inhibitors , alpha-Amylases/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL